Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating symptoms after taking ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even ...

The addition of the aldosterone synthase inhibitor helped lower blood pressure in patients with resistant hypertension.